Blockchain Registration Transaction Record
Oncotelic Therapeutics Opens Enrollment for STOP-PC Clinical Trial
Alarming increase in early-onset pancreatic cancer rates prompts Oncotelic Therapeutics to open enrollment for STOP-PC clinical trial. Potential breakthrough in pancreatic cancer treatment.
The rise in early-onset pancreatic cancer rates is a concerning trend that affects not only patients but also the healthcare industry and society as a whole. The efforts of Oncotelic Therapeutics to develop more therapeutic options for pancreatic cancer could potentially improve survival rates and quality of life for patients facing this deadly disease. The STOP-PC clinical trial holds the potential to significantly impact the future treatment of pancreatic cancer.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x0d60b1f91bd4d0c9ba37b2aef62bb97dbf922259c57dd13ad1cc37f195ecc818 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | vibeDxZB-feec2cc7caaa667fca5077686d0816d7 |